Compassionate use of remdesivir in children with COVID-19
COVID-19에 걸린 어린이를 위한 렘데시비르의 자비로운 사용
Observational Study
[키워드] adverse events
adverse outcome
adverse outcomes
age
approved
Bacterial sepsis
children
children with COVID-19
clinical
Clinical outcome
clinical status
clinical trials
Cohort
complex
Complication
complications
conducted
COVID-19
COVID-19 cases
COVID-19 disease
Critically ill
death
demonstrated
died
drug
effective
Efficacy
eight
first COVID-19 symptom
Infant
Infants
intensive care unit
IQR
Medical conditions
multicenter observational study
multicentre
observational study
Older
on children
one patient
pandemic
Patient
patients
Pediatric patients
pharmacokinetics
RDV
reached
receiving
Remdesivir
reported
SARS-CoV-2
Sepsis
severe cases
severe COVID-19 disease
severe disease
Spain
the patient
therapy
Tolerability
treat
Treatment
Trial
with COVID-19
[DOI] 10.1007/s00431-020-03876-1 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s00431-020-03876-1 PMC 바로가기 [Article Type] Observational Study